Last reviewed · How we verify
NCT06954207: ATHAPENG
Analgesia for Total Hip Arthroplasty With PENG Block (ATHAPENG)
trial testing Non interventional. Data collection concerns routine procedures and monitoring devices in Total Hip Arthroplasty for Osteoarthritis in 70 participants. Completed in 21 March 2025.
25 June 2024
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 25 June 2024 |
| Primary completion | 25 June 2024 |
| Estimated completion | 21 March 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Non interventional. Data collection concerns routine procedures and monitoring devices
Conditions studied
- Total Hip Arthroplasty for Osteoarthritis — all drugs for Total Hip Arthroplasty for Osteoarthritis →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
18 and older, any sex, with Total Hip Arthroplasty for Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Analgesia for Total Hip Arthroplasty with PENG block (ATHAPENG)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06954207
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06954207 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 1 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06954207.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing